Victory Capital Management Inc. Has $3.49 Million Holdings in Waters Co. (NYSE:WAT)

Victory Capital Management Inc. increased its stake in Waters Co. (NYSE:WAT) by 14.3% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 16,210 shares of the medical instruments supplier’s stock after purchasing an additional 2,027 shares during the quarter. Victory Capital Management Inc.’s holdings in Waters were worth $3,489,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its holdings in shares of Waters by 20.7% in the 2nd quarter. JPMorgan Chase & Co. now owns 179,470 shares of the medical instruments supplier’s stock valued at $38,312,000 after buying an additional 30,822 shares during the last quarter. Cibc World Markets Corp lifted its holdings in Waters by 278.1% during the 2nd quarter. Cibc World Markets Corp now owns 65,874 shares of the medical instruments supplier’s stock valued at $14,179,000 after purchasing an additional 48,450 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. lifted its holdings in Waters by 40.8% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 2,856 shares of the medical instruments supplier’s stock valued at $615,000 after purchasing an additional 828 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in Waters by 46.1% during the 2nd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 951 shares of the medical instruments supplier’s stock valued at $205,000 after purchasing an additional 300 shares during the last quarter. Finally, First Trust Advisors LP lifted its holdings in Waters by 1,148.3% during the 2nd quarter. First Trust Advisors LP now owns 86,505 shares of the medical instruments supplier’s stock valued at $18,619,000 after purchasing an additional 79,575 shares during the last quarter. 94.96% of the stock is owned by institutional investors.

Waters stock traded up $2.54 during mid-day trading on Thursday, hitting $224.53. 21,218 shares of the company’s stock traded hands, compared to its average volume of 583,378. The firm has a 50 day simple moving average of $216.75 and a two-hundred day simple moving average of $219.92. Waters Co. has a fifty-two week low of $167.93 and a fifty-two week high of $255.21. The stock has a market cap of $14.90 billion, a price-to-earnings ratio of 26.80, a P/E/G ratio of 2.50 and a beta of 1.07. The company has a debt-to-equity ratio of 2.00, a current ratio of 2.65 and a quick ratio of 2.07.

Waters (NYSE:WAT) last announced its quarterly earnings results on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.11 by $0.03. The business had revenue of $599.20 million during the quarter, compared to the consensus estimate of $601.46 million. Waters had a return on equity of 50.64% and a net margin of 24.09%. The company’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter last year, the firm posted $1.95 EPS. On average, research analysts anticipate that Waters Co. will post 9.01 earnings per share for the current fiscal year.

WAT has been the subject of several research reports. ValuEngine downgraded Waters from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Bank of America downgraded Waters from a “neutral” rating to an “underperform” rating in a report on Tuesday, July 16th. Finally, Cleveland Research downgraded Waters from a “neutral” rating to an “underperform” rating in a report on Wednesday, June 12th. Five investment analysts have rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the stock. Waters has a consensus rating of “Hold” and an average price target of $210.54.

Waters Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: Bond

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.